Martine Barthelet
Overview
Explore the profile of Martine Barthelet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mas J, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al.
N Engl J Med
. 2017 Sep;
377(11):1011-1021.
PMID: 28902593
Background: Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have been inconclusive. We investigated whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke would...
2.
Hypertrophic cardiomyopathy: the edge-to-edge secures the correction of the systolic anterior motion
Obadia J, Basillais N, Armoiry X, Grinberg D, Dondas A, Barthelet M, et al.
Eur J Cardiothorac Surg
. 2016 Dec;
51(4):638-643.
PMID: 28007871
Objectives: Although septal myectomy is the technique of choice for hypertrophic cardiomyopathy, the surgical management of concomitant mitral valve lesions is controversial. Various complex surgeries have been proposed to address...
3.
Mas J, Derumeaux G, Amarenco P, Arquizan C, Aubry P, Barthelet M, et al.
Int J Stroke
. 2016 Apr;
11(6):724-32.
PMID: 27056964
Rationale: Currently available data do not provide definitive evidence on the comparative benefits of closure of patent foramen ovale, oral anticoagulants and antiplatelet therapy in patients with patent foramen ovale-associated...
4.
Milleron O, Arnoult F, Ropers J, Aegerter P, Detaint D, Delorme G, et al.
Eur Heart J
. 2015 May;
36(32):2160-6.
PMID: 25935877
Aims: To evaluate the benefit of adding Losartan to baseline therapy in patients with Marfan syndrome (MFS). Methods And Results: A double-blind, randomized, multi-centre, placebo-controlled, add on trial comparing Losartan...
5.
Courand P, Barthelet M, Cordier J, Cottin V
Eur Heart J Cardiovasc Imaging
. 2012 Feb;
13(7):567.
PMID: 22334637
No abstract available.
6.
Gincul R, Lesca G, Gelas-Dore B, Rollin N, Barthelet M, Dupuis-Girod S, et al.
Hepatology
. 2008 Oct;
48(5):1570-6.
PMID: 18972447
Unlabelled: Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease characterized by cutaneous, mucosal, and sometimes visceral arteriovenous malformations. Severe hepatic manifestations have been characterized in a subgroup of patients, but...
7.
Donal E, Thibault H, Bergerot C, Leroux P, Cannesson M, Thivolet S, et al.
Arch Cardiovasc Dis
. 2008 Oct;
101(7-8):475-84.
PMID: 18848690
Background: Cardiac resynchronization therapy (CRT) produces an early improvement in left ventricular (LV) function in patients with congestive heart failure (CHF), but little is known about its effects on right...
8.
Stephant E, Barthelet M, Leroux P, Revel D
Circulation
. 2008 Jul;
118(4):e71-2.
PMID: 18645059
No abstract available.
9.
Nighoghossian N, Cakmak S, Derex L, Barthelet M, Thibault H, Finet G, et al.
Eur Neurol
. 2006 Oct;
56(4):211-6.
PMID: 17057380
Background: Several testing options are available to detect asymptomatic coronary artery disease (CAD). Dobutamine stress echocardiography (DSE) has been reported to increase the sensitivity and specificity of stress testing to...
10.
Jondeau G, Barthelet M, Baumann C, Bonnet D, Chevallier B, Collignon P, et al.
Arch Mal Coeur Vaiss
. 2006 Jun;
99(5):540-6.
PMID: 16802751
No abstract available.